Interferon gamma release assay
Interferon gamma release assay (IGRA) is a medical test used to detect infection with Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). The test measures the immune system's response to TB bacteria by testing the patient's blood for the presence of interferon gamma, a type of cytokine that is released by T cells in response to infection.
Etymology[edit | edit source]
The term "interferon gamma release assay" is derived from the function of the test. "Interferon gamma" refers to the specific cytokine that the test measures, while "release assay" refers to the method of testing, which involves measuring the amount of interferon gamma released by T cells in response to TB bacteria.
Procedure[edit | edit source]
The IGRA test involves drawing blood from the patient and incubating it with antigens (substances that trigger an immune response) derived from M. tuberculosis. If the patient's immune system has been exposed to TB bacteria, the T cells in the blood sample will release interferon gamma. The amount of interferon gamma in the sample is then measured to determine whether the patient has a TB infection.
Types of IGRA[edit | edit source]
There are two types of IGRA tests: the QuantiFERON-TB Gold In-Tube test (QFT-GIT) and the T-SPOT.TB test. Both tests are approved by the U.S. Food and Drug Administration (FDA) for the detection of TB infection.
Interpretation[edit | edit source]
A positive IGRA result indicates that the patient's immune system has been exposed to TB bacteria. However, it does not distinguish between latent TB infection (LTBI) and active TB disease. Additional tests are needed to confirm the diagnosis and determine the stage of the disease.
Advantages and Limitations[edit | edit source]
IGRA tests have several advantages over the traditional tuberculin skin test (TST), including greater specificity and the need for only one patient visit. However, they also have limitations, such as the inability to distinguish between LTBI and active TB disease, and the potential for false-positive results in patients who have been vaccinated with the Bacillus Calmette-Guérin (BCG) vaccine.
See Also[edit | edit source]
- Tuberculosis
- Mycobacterium tuberculosis
- Interferon gamma
- Cytokine
- T cells
- Antigen
- U.S. Food and Drug Administration
- Tuberculin skin test
- Bacillus Calmette-Guérin
Interferon gamma release assay Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD